Company search
Overview
Performance
Portfolio
ESG
Dividends
Charges
Gearing
Research
Announcements
Management
Documents
Invest
Data as at: 22/04/2024
In
Objective
To achieve superior long-term capital appreciation from its investments. The Company invests in life science businesses and single or multi-asset projects.
AIC sector
Management group
Syncona Investment Management Limited
Company website
Launch date
26/10/2012
March
Domicile
Guernsey
Fund manager
Chris Hollowood
Dividend frequency
Annually
Wind-up provisions
The Company has an unlimited life.
| Market Cap (m) | Total assets (m) | Price (last close) | NAV | Discount / premium (%) | Gearing (%) | Dividend yield (%) | Dividend dates | Ongoing charge (%) |
|---|---|---|---|---|---|---|---|---|
| 810.28 | 1,229.80 | 124.00 | 188.20 | -34.11 | 0 | 0.00 | Jul | 0.88 (31/03/2023) |
Scroll
Dividends
Dividends declared in last 12 months
There have been no dividends in the last 12 months.
Performance (%)
| Return type | 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|---|
| Syncona | Share price total return | -18.5 | -46.1 | -51.1 | 11.8 |
| Biotechnology & Healthcare AIC sector | Share price total return | -2.4 | -21.9 | 3.6 | 121.9 |
Scroll
Share structure
Number of shares
653,455,586
18,351,080
Traded volumes (number of shares)
| Yesterday | 1 month | 1 year | 5 years | |
|---|---|---|---|---|
| Total | 377,097 | 12,196,710 | 182,600,787 | 887,261,518 |
| Average | N/A | 590,553 | 716,976 | 703,359 |
Scroll
Traded values (m)
| Yesterday | 1 month | 1 year | 5 years | |
|---|---|---|---|---|
| Total | 0.47 | 14.85 | 233.84 | 1,722.54 |
| Average | N/A | 0.72 | 0.92 | 1.37 |
Scroll
Trading details
Top holdings
Data as at : 30/09/2023
| Investment | % of total assets |
|---|---|
| Quell Therapeutics Limited | 7.3 |
| SwanBio Therapeutics Limited | 6.4 |
| Beacon Therapeutics Holdings Limited1 | 6.2 |
| Anaveon AG | 5.4 |
| Autolus Therapeutics plc | 5.3 |
| OMass Therapeutics Limited | 3.6 |
| Resolution Therapeutics Limited | 3.2 |
| Purespring Therapeutics Limited | 2.9 |
| Clade Therapeutics Inc | 2.0 |
| Cambridge Epigenetix Limited | 1.6 |
Data provided by Morningstar.
Company documents provided by FE fundinfo.
